Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02204566 · ClinicalTrials.gov registry record · NA

OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) Ablation

A NA study of Atrial Fibrillation, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT02204566 is a NA study of Atrial Fibrillation that has completed, run by Massachusetts General Hospital. The registered enrollment target is 6 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02204566, a NA study of Atrial Fibrillation, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

12 patients with Atrial Fibrillation, a kind of irregular heart beat who have undergone Radio frequency (RF) ablation will be asked to swallow the capsule. As they swallow the capsule, images of the esophagus will be taken to see if the RF ablation caused any form of damage to the esophagus considering it being so close to the heart. After the capsule has been removed from the mouth, they will be asked about the tolerability of the capsule.

Conditions Studied

Interventions

  • DEVICE OFDI Capsule

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2013-01
Est. Completion 2015-09
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT02204566

The ClinicalTrials.gov registry entry for NCT02204566 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (100% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which OFDI Capsule is the first listed.

NCT02204566 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02204566 about?

NCT02204566 is a clinical study titled "OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) Ablation". 12 patients with Atrial Fibrillation, a kind of irregular heart beat who have undergone Radio frequency (RF) ablation will be asked to swallow the capsule. As they swallow the capsule, images of the esophagus will be taken to see if the RF ablation caused any form of damage to the esophagus conside...

What is the current status of trial NCT02204566?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2013-01. Estimated completion is 2015-09.

What conditions does trial NCT02204566 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT02204566?

The interventions under investigation include: OFDI Capsule (DEVICE).

Who is sponsoring clinical trial NCT02204566?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02204566 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.